Target Price | $2.18 |
Price | $1.16 |
Potential |
87.81%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target IGM Biosciences Inc 2026 .
The average IGM Biosciences Inc target price is $2.18.
This is
87.81%
register free of charge
$3.00
158.62%
register free of charge
$1.50
29.31%
register free of charge
|
|
A rating was issued by 8 analysts: 0 Analysts recommend IGM Biosciences Inc to buy, 7 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IGM Biosciences Inc stock has an average upside potential 2026 of
87.81%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 2.68 | 5.43 |
25.82% | 102.52% | |
EBITDA Margin | -6,907.09% | -810.85% |
42.35% | 88.26% | |
Net Margin | -7,211.42% | -1,055.05% |
45.33% | 85.37% |
8 Analysts have issued a sales forecast IGM Biosciences Inc 2025 . The average IGM Biosciences Inc sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an IGM Biosciences Inc EBITDA forecast 2025. The average IGM Biosciences Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 IGM Biosciences Inc Analysts have issued a net profit forecast 2025. The average IGM Biosciences Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.24 | -0.96 |
31.21% | 70.37% | |
P/E | negative | |
EV/Sales | negative |
5 Analysts have issued a IGM Biosciences Inc forecast for earnings per share. The average IGM Biosciences Inc EPS is
This results in the following potential growth metrics and future valuations:
IGM Biosciences Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Locked
➜
Locked
|
Locked | Jan 13 2025 |
BMO Capital |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
Jefferies |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
BMO Capital |
Locked
➜
Locked
|
Locked | Dec 06 2024 |
Analyst Rating | Date |
---|---|
Locked
JP Morgan:
Locked
➜
Locked
|
Jan 13 2025 |
Locked
BMO Capital:
Locked
➜
Locked
|
Jan 10 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Jan 10 2025 |
Locked
Jefferies:
Locked
➜
Locked
|
Jan 10 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Jan 10 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Jan 10 2025 |
Locked
BMO Capital:
Locked
➜
Locked
|
Dec 06 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.